CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine (NASDAQ:FMI) today announced that Michael J. Pellini, M.D.,
chief executive officer, is scheduled to present at the 35th Annual J.P.
Morgan Healthcare Conference on Tuesday, January 10, 2017 at 9:00 a.m.
PST in San Francisco.
A live, listen-only webcast of the presentation can be accessed by
visiting the investors section of the Foundation Medicine website at investors.foundationmedicine.com.
A replay of the webcast will be available shortly after the conclusion
of the presentation and archived on the company's website for 90 days
following the presentation.
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company offers a full suite of
comprehensive genomic profiling assays to identify the molecular
alterations in a patient's cancer and match them with relevant targeted
therapies, immunotherapies and clinical trials. Foundation Medicine's
molecular information platform aims to improve day-to-day care for
patients by serving the needs of clinicians, academic researchers and
drug developers to help advance the science of molecular medicine in
cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered
trademark of Foundation Medicine, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170103005334/en/
Pure Communications, Inc.
Kimberly Brown, 617-418-2215
Source: Foundation Medicine
News Provided by Acquire Media